These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 31101744

  • 21. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.
    Li XY, Men WW, Zhu H, Lei JF, Zuo FX, Wang ZJ, Zhu ZH, Bao XJ, Wang RZ.
    Int J Mol Sci; 2016 Oct 18; 17(10):. PubMed ID: 27763550
    [Abstract] [Full Text] [Related]

  • 22. Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J.
    Kumar A, Scarpa M, Nordberg A.
    Alzheimers Dement; 2024 Apr 18; 20(4):2589-2605. PubMed ID: 38363009
    [Abstract] [Full Text] [Related]

  • 23. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
    Zhang Y, Huang LJ, Shi S, Xu SF, Wang XL, Peng Y.
    CNS Neurosci Ther; 2016 Dec 18; 22(12):979-987. PubMed ID: 27439966
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11 C]UCB-J.
    Mecca AP, O'Dell RS, Sharp ES, Banks ER, Bartlett HH, Zhao W, Lipior S, Diepenbrock NG, Chen MK, Naganawa M, Toyonaga T, Nabulsi NB, Vander Wyk BC, Arnsten AFT, Huang Y, Carson RE, van Dyck CH.
    Alzheimers Dement; 2022 Dec 18; 18(12):2527-2536. PubMed ID: 35174954
    [Abstract] [Full Text] [Related]

  • 26. Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [11C]UCB-J PET.
    Young JJ, O'Dell RS, Naganawa M, Toyonaga T, Chen MK, Nabulsi NB, Huang Y, Cooper E, Miller A, Lam J, Bates K, Ruan A, Nelsen K, Salardini E, Carson RE, van Dyck CH, Mecca AP.
    J Nucl Med; 2024 Nov 01; 65(11):1782-1785. PubMed ID: 39299782
    [Abstract] [Full Text] [Related]

  • 27. Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study.
    Chen MK, Mecca AP, Naganawa M, Gallezot JD, Toyonaga T, Mondal J, Finnema SJ, Lin SF, O'Dell RS, McDonald JW, Michalak HR, Vander Wyk B, Nabulsi NB, Huang Y, Arnsten AF, van Dyck CH, Carson RE.
    J Cereb Blood Flow Metab; 2021 Sep 01; 41(9):2395-2409. PubMed ID: 33757318
    [Abstract] [Full Text] [Related]

  • 28. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
    Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K, Seibyl JP, Tamagnan GD, Barret O.
    Mol Imaging Biol; 2019 Jun 01; 21(3):509-518. PubMed ID: 30084043
    [Abstract] [Full Text] [Related]

  • 29. Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain.
    Thomsen MB, Schacht AC, Alstrup AKO, Jacobsen J, Lillethorup TP, Bærentzen SL, Noer O, Orlowski D, Elfving B, Müller HK, Brooks DJ, Landau AM.
    Mol Imaging Biol; 2020 Oct 01; 22(5):1290-1300. PubMed ID: 32514885
    [Abstract] [Full Text] [Related]

  • 30. Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [18F]SDM-16.
    Zheng C, Toyonaga T, Chen B, Nicholson L, Mennie W, Liu M, Spurrier J, Deluca K, Strittmatter SM, Carson RE, Huang Y, Cai Z.
    Front Neurol; 2023 Oct 01; 14():1045644. PubMed ID: 36846134
    [Abstract] [Full Text] [Related]

  • 31. Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.
    Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, Gallezot JD, Henry S, Hannestad J, Huang Y, Carson RE.
    J Cereb Blood Flow Metab; 2018 Nov 01; 38(11):2041-2052. PubMed ID: 28792356
    [Abstract] [Full Text] [Related]

  • 32. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, Yin XP, Wang W.
    Behav Brain Res; 2016 Sep 15; 311():309-321. PubMed ID: 27233830
    [Abstract] [Full Text] [Related]

  • 33. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles.
    Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas CA, Declercq R, Reynders T, Telan-Choing NF, Riffel K, Celen S, Serdons K, Bormans G, Tsai K, Walji A, Hostetler ED, Evelhoch JL, Van Laere K, Forman M, Stoch A, Sur C, Struyk A.
    J Nucl Med; 2019 Jan 15; 60(1):107-114. PubMed ID: 29880509
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F, Wei G, Bai Y, Li Y, Huang F, Lin J, Hou Q, Deng R, Zhou JH, Zhang SX, Chen DF.
    Brain Res; 2015 Nov 19; 1627():177-88. PubMed ID: 26423933
    [Abstract] [Full Text] [Related]

  • 35. In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
    Mecca AP, Chen MK, O'Dell RS, Naganawa M, Toyonaga T, Godek TA, Harris JE, Bartlett HH, Zhao W, Nabulsi NB, Wyk BCV, Varma P, Arnsten AFT, Huang Y, Carson RE, van Dyck CH.
    Alzheimers Dement; 2020 Jul 19; 16(7):974-982. PubMed ID: 32400950
    [Abstract] [Full Text] [Related]

  • 36. First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.
    Naganawa M, Li S, Nabulsi N, Henry S, Zheng MQ, Pracitto R, Cai Z, Gao H, Kapinos M, Labaree D, Matuskey D, Huang Y, Carson RE.
    J Nucl Med; 2021 Apr 19; 62(4):561-567. PubMed ID: 32859701
    [Abstract] [Full Text] [Related]

  • 37. Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor.
    Ryskamp D, Wu L, Wu J, Kim D, Rammes G, Geva M, Hayden M, Bezprozvanny I.
    Neurobiol Dis; 2019 Apr 19; 124():489-504. PubMed ID: 30594810
    [Abstract] [Full Text] [Related]

  • 38. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
    Faivre E, Hölscher C.
    J Alzheimers Dis; 2013 Apr 19; 35(2):267-83. PubMed ID: 23568101
    [Abstract] [Full Text] [Related]

  • 39. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging.
    Vogler L, Ballweg A, Bohr B, Briel N, Wind K, Antons M, Kunze LH, Gnörich J, Lindner S, Gildehaus FJ, Baumann K, Bartenstein P, Boening G, Ziegler SI, Levin J, Zwergal A, Höglinger GU, Herms J, Brendel M.
    Neuroimage Clin; 2023 Apr 19; 39():103484. PubMed ID: 37541098
    [Abstract] [Full Text] [Related]

  • 40. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A, López-Picón FR, Rokka J, Salmona M, Forloni G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M.
    J Nucl Med; 2013 Aug 19; 54(8):1434-41. PubMed ID: 23833271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.